EnginZyme, a cell-free synthetic biology technology company. EnginZyme was founded in 2014 based on the invention of Dr Karim Engelmark Cassimjee of a disruptive enzyme immobilisation technology (EziG) which could pave the way for biocatalysis to be more economically utilised. EnginZyme has developed a platform for chemical production, the cell-free synbio solution, based on the disruptive immobilisation technology, EziG. It marries the efficiency of the traditional chemical process with the sustainability of enzymatic catalysis. By taking the work horses (enzymes) out of the cell, EnginZyme offers a cost-efficient sustainable processing solution which can compete with traditional petroleum-derived chemistry. EnginZyme has developed stable heterogenous enzyme catalysts suitable for flow chemistry. This use of enzymes in flow is unique and makes biology-based chemistry scalable, fast and with a small environmental footprint. Composed of a multidisciplinary team of experts in biocatalysis, organic chemistry, enzyme engineering, process engineering and automation, EnginZyme has facilities for complete research and process development incorporating high degree of automation for fast, accurate development. EnginZyme is now utilising its technology platform to provide enzymatic RnD support as well as develop processes for products to be licensed or brought to market by EnginZyme in collaboration with key chemical industry partners.